ブライトパス.バイオ株式会社 · BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Last · Tokyo¥42.00-1.00 (-2.33%)close · yahoo · 13h ago
Market cap¥5.8B138.9M sh
P/E · TTM-3.3fwd — · eps -12.63 · loss
Beta1.31vs S&P 500
Div yield0.00%annual · TTM
52w range
¥41.00¥96.00
Volume1.2Msession
| Revenue | ¥155.8M |
|---|---|
| Operating income | ¥-1.7B |
| Net income | ¥-1.9B |
| Free cash flow | ¥-1.6B |
| Operating margin | -1069.0% |
| Net margin | -1209.4% |
| Return on equity | -37.5% |
| Period | 2019 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-06-25
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.6 years
- Accumulated Deficit High — Accumulated deficit / equity 216%
- Rd Intensity High — R&D/Revenue 1193444.0%
Documents
FormReporting forFiledFlags